Financials

  • Market Capitalization 95.95 M
  • Employee 4
  • Founded 1982
  • CEO N/A
  • Website www.anixa.com
  • Headquarter Delaware, United States
  • FIGI BBG000BG3J79
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-12.15
ratio cours/chiffre d'affaires
—

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
3855
BDTX
Black Diamond Therapeutics, Inc. - Common Stock
1.72 USD-2.82%-10.42%-13.13%-54.26%98.82 M USD
3857
MIST
Milestone Pharmaceuticals Inc. - Common Shares
0.79 USD-2.47%+2.60%-20.20%-60.10%98.35 M USD
3866
BMEA
Biomea Fusion, Inc. - Common Stock
1.38 USD+1.47%+7.81%-19.30%-15.34%100.03 M USD
3872
AARD
Aardvark Therapeutics, Inc. - Common Stock
4.45 USD-6.51%-12.06%-9.18%-64.71%97.39 M USD

Nouvelles